ClinicalTrials.Veeva

Menu

Comparison of 19g FNA and 19g FNB Needles for EUS-LB

Geisinger Health logo

Geisinger Health

Status

Completed

Conditions

Abnormal Liver Function

Treatments

Device: 19-gauge FNA needle
Device: 19-gauge FNB needle

Study type

Interventional

Funder types

Other

Identifiers

NCT03408171
2017-0391

Details and patient eligibility

About

Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an important method for helping to determine the etiology and stage of LD. Percutaneous liver biopsy (PLB), transjugular liver biopsy (TLB) and surgical liver biopsy (SLB) are alternative methods for obtaining hepatic tissue. In recent years endoscopic ultrasound guided-liver biopsy (EUS-LB) has come to the forefront as a safe and effective method for obtaining tissue in CLD. There are several studies of the safety of EUS-LB as well as the adequacy of specimens obtained in this fashion. Most studies involve a 19-g needle, therefore in this study we hope to compare the tissue yields of a 19-g fine needle biopsy (FNB) needle, in comparison to conventional 19-g fine needle aspiration (FNA) needle. We predict that 19-g FNA and 19-g FNB needle will demonstrate similar diagnostic accuracy, with less visible blood artifact. Similarly, we predict the safety to be equal.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients undergoing EUS-LB
  2. Platelet count > 50,000
  3. International normalized ratio (INR) < 1.5
  4. Age > 18 years
  5. Non-pregnant patients

Exclusion criteria

  1. Age < 18 years
  2. Pregnant patients
  3. Inability to obtain consent
  4. Anticoagulants or anti-platelet agents use (excluding aspirin) within the last 7-10 days
  5. Platelet count < 50,000
  6. INR > 1.5
  7. Presence of ascites
  8. Known liver cirrhosis
  9. Hemophilia

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

19-gauge FNA needle
Active Comparator group
Description:
A 19-gauge FNA needle will be used to obtain liver tissue during an endoscopic-ultrasound guided liver biopsy. Tissue yield and diagnostic accuracy will be assessed and compared to that of the 19-gauge FNB needle.
Treatment:
Device: 19-gauge FNA needle
19-gauge FNB needle
Active Comparator group
Description:
A 19-gauge FNB needle will be used to obtain liver tissue during an endoscopic-ultrasound guided liver biopsy. Tissue yield and diagnostic accuracy will be assessed and compared to that of the 19-gauge FNA needle.
Treatment:
Device: 19-gauge FNB needle

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems